Half-year report · HY
4978.TEDINET S100X33R
Period2025-04-01 → 2025-09-30
Filed2025-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 43
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥974m | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥3.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.3bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | −¥547m | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | −¥149m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | −¥483m | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥45m | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥103m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | −¥483m | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | −¥103m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥486m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥103m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥104m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥486m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | −¥104m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥9.4bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥9.7bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥9.4bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥688m | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥686m | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥8.7bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥9.0bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥8.7bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.6bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.8bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.6bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.8bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.0bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.9bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥342m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥6m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥131m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | ¥123m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥796m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥412m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥680m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥681m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-5.14 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥1.11 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-1.14 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 92.7% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 92.9% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 92.8% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment ordinary income | 2025-04-01 → 2025-09-30 | −¥341m |
| Medical Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥87m |
| Medical Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥87m |
| Medical Businessreportable segment | segment ordinary income | 2025-04-01 → 2025-09-30 | −¥119m |
| Research Support Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥887m |
| Research Support Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥887m |
| Research Support Businessreportable segment | segment ordinary income | 2025-04-01 → 2025-09-30 | −¥23m |
| —segment total | revenue | 2025-04-01 → 2025-09-30 | ¥974m |
| —segment total | revenue external | 2025-04-01 → 2025-09-30 | ¥974m |
| —segment total | segment ordinary income | 2025-04-01 → 2025-09-30 | −¥142m |
| Reconciling Itemsreconciling | segment ordinary income | 2024-04-01 → 2024-09-30 | −¥378m |
| Medical Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥176m |
| Medical Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥176m |
| Medical Businessreportable segment | segment ordinary income | 2024-04-01 → 2024-09-30 | ¥8m |
| Research Support Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥1.1bn |
| Research Support Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥1.1bn |
| Research Support Businessreportable segment | segment ordinary income | 2024-04-01 → 2024-09-30 | ¥267m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥1.3bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥1.3bn |
| —segment total | segment ordinary income | 2024-04-01 → 2024-09-30 | ¥275m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 470
| Item | Context | Value | Unit |
|---|---|---|---|
| Current liabilities | Prior1YearInstant | 640585000 | JPY |
| Current liabilities | InterimInstant | 591914000 | JPY |
| Deferred tax liabilities | Prior1YearInstant | 35206000 | JPY |
| Deferred tax liabilities | InterimInstant | 86610000 | JPY |
| Asset retirement obligations ncl | Prior1YearInstant | 9081000 | JPY |
| Asset retirement obligations ncl | InterimInstant | 9103000 | JPY |
| Other ncl | Prior1YearInstant | 935000 | JPY |
| Other ncl | InterimInstant | 588000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 45223000 | JPY |
| Noncurrent liabilities | InterimInstant | 96302000 | JPY |
| Liabilities | Prior1YearInstant | 685808000 | JPY |
| Liabilities | InterimInstant | 688217000 | JPY |
| Capital stock | Prior1YearInstant | 2688926000 | JPY |
| Capital stock | InterimInstant | 2688926000 | JPY |
| Capital surplus | Prior1YearInstant | 6244884000 | JPY |
| Capital surplus | InterimInstant | 6244884000 | JPY |
| Retained earnings | Prior1YearInstant | 58294000 | JPY |
| Retained earnings | InterimInstant | -428046000 | JPY |
| Treasury stock | Prior1YearInstant | -916000 | JPY |
| Treasury stock | InterimInstant | -916000 | JPY |
| Shareholders equity | Prior1YearInstant | 8991188000 | JPY |
| Shareholders equity | InterimInstant | 8504847000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | -13677000 | JPY |
| Valuation difference on available for sale securities | InterimInstant | 162992000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 7435000 | JPY |
| Foreign currency translation adjustment | InterimInstant | 7632000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | -6242000 | JPY |
| Valuation and translation adjustments | InterimInstant | 170624000 | JPY |
| Net assets | Prior1YearInstant | 8984946000 | JPY |
| Net assets | InterimInstant | 8675472000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 9670755000 | JPY |
| Liabilities and net assets | InterimInstant | 9363689000 | JPY |
| Net sales of finished goods rev oa | Prior1InterimDuration | 734409000 | JPY |
| Net sales of finished goods rev oa | InterimDuration | 549788000 | JPY |
| Service revenue rev oa | Prior1InterimDuration | 586004000 | JPY |
| Service revenue rev oa | InterimDuration | 424277000 | JPY |
| Net sales | Prior1InterimDuration | 1320413000 | JPY |
| Net sales | InterimDuration | 974065000 | JPY |
| Cost of finished goods sold | Prior1InterimDuration | 377503000 | JPY |
| Cost of finished goods sold | InterimDuration | 363229000 | JPY |
| Cost of service operations cos | Prior1InterimDuration | 236290000 | JPY |
| Cost of service operations cos | InterimDuration | 223890000 | JPY |
| Cost of sales | Prior1InterimDuration | 613794000 | JPY |
| Cost of sales | InterimDuration | 587119000 | JPY |
| Gross profit | Prior1InterimDuration | 706619000 | JPY |
| Gross profit | InterimDuration | 386946000 | JPY |
| Research and development expenses sga | Prior1InterimDuration | 236622000 | JPY |
| Research and development expenses sga | InterimDuration | 308505000 | JPY |
| Other selling general and administrative expenses sga | Prior1InterimDuration | 619173000 | JPY |
| Other selling general and administrative expenses sga | InterimDuration | 625071000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |